학술논문

Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice
Document Type
Article
Source
In: American Journal of Hematology. (American Journal of Hematology, 1 July 2021, 96(7):790-795)
Subject
Language
English
ISSN
10968652
03618609